Is Helicobacter pylori Anyway Pathogen in Children?
Marco Manfredi1, Pierpacifico Gismondi2, Silvia Iuliano3
1Azienda USL-IRCCS di Reggio Emilia, Maternal and Child Department, Pediatric Unit, Sant'Anna Hospital, Castelnovo ne Monti, Reggio Emilia, Italy.
Helicobacter pylori (H. pylori) infection poses challenges for pediatric care. Current evidence suggests H. pylori may be pathogenic in children, warranting treatment considerations, especially in Eastern countries.
Area of Science:
- Pediatric Gastroenterology
- Infectious Diseases
- Microbiology
Background:
- Helicobacter pylori (H. pylori) infection presents diagnostic and treatment challenges, with differing international guidelines for adults and children.
- Pediatric guidelines are often more restrictive due to lower incidence of severe consequences in Western countries.
- Recent research indicates a broader pathological role for H. pylori, even in asymptomatic children.
Purpose of the Study:
- To evaluate the current evidence regarding H. pylori infection in children.
- To discuss the potential for treating H. pylori in pre-adolescent children, particularly in Eastern countries.
- To re-evaluate the pathogenic role of H. pylori in pediatric populations.
Main Methods:
- Review of current international guidelines for H. pylori diagnosis and treatment in children.
- Analysis of recent studies on the pathological role of H. pylori in pediatric populations.
- Consideration of emerging evidence on gastric damage biomarkers in children.
Main Results:
- International guidelines for pediatric H. pylori management are more conservative than for adults.
- H. pylori infection is increasingly recognized for its pathological role in children, including asymptomatic cases.
- Biomarkers of gastric damage are developing in pre-adolescent children's stomachs.
Conclusions:
- H. pylori-infected children may benefit from treatment starting in pre-adolescence, especially in Eastern countries.
- The study supports the view that H. pylori is pathogenic in children.
- The potential beneficial role of H. pylori in humans remains an area for further investigation.
More Related Videos
10:44One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
